These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27544029)

  • 21. Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes.
    Zheng XY; Yu BL; Xie YF; Zhao SP; Wu CL
    Mol Med Rep; 2017 Nov; 16(5):6771-6779. PubMed ID: 28901468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.
    Feng Q; Baker SS; Liu W; Arbizu RA; Aljomah G; Khatib M; Nugent CA; Baker RD; Forte TM; Hu Y; Zhu L
    Pathology; 2015 Jun; 47(4):341-8. PubMed ID: 25938357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.
    Huang PP; Zhu WQ; Xiao JM; Zhang YQ; Li R; Yang Y; Shen L; Luo F; Dai W; Lian PA; Tang YX; Ran JL; Huang XS
    Front Pharmacol; 2022; 13():935362. PubMed ID: 36034782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
    Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
    Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
    Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
    World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.
    Li R; Zhu W; Huang P; Yang Y; Luo F; Dai W; Shen L; Pei W; Huang X
    Biomed Pharmacother; 2021 Sep; 141():111803. PubMed ID: 34146854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertriglyceridemia in obese subjects: caused by reduced apolipoprotein A5 plasma levels?
    Heeren J; Merkel M
    Atherosclerosis; 2010 Oct; 212(2):386-7. PubMed ID: 20638662
    [No Abstract]   [Full Text] [Related]  

  • 31. Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.
    Evans D; Aberle J; Beil FU
    Atherosclerosis; 2011 Dec; 219(2):715-20. PubMed ID: 21993410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries.
    Yang Y; Konrad RJ; Ploug M; Young SG
    J Lipid Res; 2024 Jul; 65(7):100578. PubMed ID: 38880127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver.
    Tessari P; Tiengo A
    Acta Diabetol; 2008 Sep; 45(3):143-5. PubMed ID: 18357405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Effect of Metformin on Postprandial Hypertriglyceridemia through Delayed Gastric Emptying.
    Sato D; Morino K; Nakagawa F; Murata K; Sekine O; Beppu F; Gotoh N; Ugi S; Maegawa H
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.
    Pisciotta L; Fresa R; Bellocchio A; Guido V; Priore Oliva C; Calandra S; Bertolini S
    Clin Chim Acta; 2011 Nov; 412(23-24):2194-8. PubMed ID: 21846464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants.
    Hubacek JA
    Clin Chem Lab Med; 2005; 43(9):897-902. PubMed ID: 16176166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene.
    Priore Oliva C; Carubbi F; Schaap FG; Bertolini S; Calandra S
    J Intern Med; 2008 Apr; 263(4):450-8. PubMed ID: 18324930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content.
    Zheng XY; Zhao SP; Yu BL; Wu CL; Liu L
    Biol Chem; 2012 Mar; 393(3):161-7. PubMed ID: 22718631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.